Financial results - CYTOGENIS SRL

Financial Summary - Cytogenis Srl
Unique identification code: 30130975
Registration number: J22/723/2012
Nace: 8622
Sales - Ron
105.595
Net Profit - Ron
6.742
Employee
2
The most important financial indicators for the company Cytogenis Srl - Unique Identification Number 30130975: sales in 2023 was 105.595 euro, registering a net profit of 6.742 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Cytogenis Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 25.393 30.124 31.686 45.139 31.456 35.054 30.762 64.380 81.580 105.595
Total Income - EUR 25.855 30.124 31.686 45.139 31.456 35.054 30.817 64.380 81.580 105.598
Total Expenses - EUR 25.031 17.958 12.838 25.948 22.992 29.960 20.018 22.484 34.934 97.800
Gross Profit/Loss - EUR 823 12.166 18.848 19.190 8.464 5.095 10.799 41.896 46.646 7.798
Net Profit/Loss - EUR 69 11.307 18.198 17.450 7.506 4.041 9.876 39.928 44.627 6.742
Employees 0 0 0 1 1 1 1 0 1 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 29.8%, from 81.580 euro in the year 2022, to 105.595 euro in 2023. The Net Profit decreased by -37.749 euro, from 44.627 euro in 2022, to 6.742 in the last year.

Check the financial reports for the company - Cytogenis Srl

Rating financiar

Financial Rating -
Cytogenis Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Cytogenis Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Cytogenis Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Cytogenis Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Cytogenis Srl - CUI 30130975

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 10.561 3.854 2.606 37.928 33.512 35.787 31.929 28.968 22.871 52.717
Current Assets 18.786 36.699 56.415 38.941 23.431 27.866 38.995 80.210 96.921 63.344
Inventories 8.220 10.137 12.398 8.335 9.358 13.322 13.103 18.698 20.197 13.799
Receivables 114 1.280 2.461 2.736 3.662 4.186 5.219 5.462 19.828 36.603
Cash 10.452 25.282 41.556 27.871 10.411 10.358 20.673 56.050 56.896 12.942
Shareholders Funds -3.947 7.328 25.481 42.628 49.351 52.436 61.319 99.886 102.816 80.679
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 33.294 33.225 33.539 34.242 7.592 11.217 9.605 9.292 16.976 35.382
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 63.344 euro in 2023 which includes Inventories of 13.799 euro, Receivables of 36.603 euro and cash availability of 12.942 euro.
The company's Equity was valued at 80.679 euro, while total Liabilities amounted to 35.382 euro. Equity decreased by -21.825 euro, from 102.816 euro in 2022, to 80.679 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Cytogenis Srl

Comments - Cytogenis Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.